Clinical Trials Logo

Clinical Trial Summary

The study aims to examine a battery of behavioral and questionnaire measures in 4 disorders clinically associated with impulsivity and in health controls, to: 1) investigate if the different populations have a distinct behavioral profile, and 2) to investigate if there are specific measures that are reliable and sensitive measures of impulsivity across diagnoses.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02722174
Study type Observational
Source Boehringer Ingelheim
Contact
Status Completed
Phase
Start date July 22, 2016
Completion date September 6, 2018

See also
  Status Clinical Trial Phase
Completed NCT00115011 - Escitalopram for the Treatment of Self-Injurious Skin Picking Phase 4
Completed NCT02319395 - Behavioural Addiction and Genetics in Parkinson's Disease N/A
Recruiting NCT03970239 - Serotonin in Impulse Control Disorders in Parkinson's Disease N/A
Completed NCT03887429 - Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal Phase 2
Completed NCT02755181 - fMRI in Impulsivity
Enrolling by invitation NCT01354236 - Mental Health Related to School Dropout in Luxembourg N/A
Completed NCT00118014 - Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania Phase 4
Recruiting NCT02796040 - Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography. N/A
Not yet recruiting NCT02934919 - Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study Phase 2